E-LIB Suche - Ergebnisse für: Hegg, Roberto

1

Prognostic Factors and Survival Outcomes of Patients With E..:

Mattar, André ; Hegg, Roberto ; Tayar, Daiane O....
Clinical Breast Cancer. 23 (2023) 8 - p. 864-875.e7 , 2023

Link: https://doi.org/10.1016/..

2

Trastuzumab deruxtecan versus trastuzumab emtansine in pati..:

Hurvitz, Sara A ; Hegg, Roberto ; Chung, Wei-Pang...
The Lancet. 401 (2023) 10371 - p. 105-117 , 2023

Link: https://doi.org/10.1016/..

3

nextMONARCH Phase 2 randomized clinical trial: overall surv..:

Hamilton, Erika ; Cortes, Javier ; Ozyilkan, Ozgur...
Breast Cancer Research and Treatment. 195 (2022) 1 - p. 55-64 , 2022

Link: https://doi.org/10.1007/..

4

nextMONARCH: Abemaciclib Monotherapy or Combined With Tamox..:

Hamilton, Erika ; Cortes, Javier ; Ozyilkan, Ozgur...
Clinical Breast Cancer. 21 (2021) 3 - p. 181-190.e2 , 2021

Link: https://doi.org/10.1016/..

5

A Long-Term Extension Study of Bevacizumab in Patients With..:

Oza, Amit M. ; Dubois, François ; Hegg, Roberto...
The Oncologist. 26 (2021) 12 - p. e2254-e2264 , 2021

Link: https://doi.org/10.1002/..

6

FLABRA, Frontline Approach forBRCATesting in an Ovarian Can..:

Giornelli, Gonzalo ; Gallardo, Dolores ; Hegg, Roberto...
Future Oncology. 17 (2021) 13 - p. 1601-1609 , 2021

Link: https://doi.org/10.2217/..

7

Neoadjuvant atezolizumab in combination with sequential nab..:

Mittendorf, Elizabeth A ; Zhang, Hong ; Barrios, Carlos H...
The Lancet. 396 (2020) 10257 - p. 1090-1100 , 2020

Link: https://doi.org/10.1016/..

8

MONARCH plus: abemaciclib plus endocrine therapy in women w..:

Zhang, Qing Yuan ; Sun, Tao ; Yin, Yong Mei...
Therapeutic Advances in Medical Oncology. 12 (2020) - p. 175883592096392 , 2020

Link: https://doi.org/10.1177/..

9

Randomized phase II study evaluating weekly oral vinorelbin..:

Aapro, Matti ; Ruiz-Borrego, Manuel ; Hegg, Roberto...
The Breast. 45 (2019) - p. 7-14 , 2019

Link: https://doi.org/10.1016/..

10

Ribociclib with letrozole vs letrozole alone in elderly pat..:

Sonke, Gabe S. ; Hart, Lowell L. ; Campone, Mario...
Breast Cancer Research and Treatment. 167 (2017) 3 - p. 659-669 , 2017

Link: https://doi.org/10.1007/..

11

Safety and tolerability of subcutaneous trastuzumab for the..:

Gligorov, J. ; Ataseven, B. ; Verrill, M....
European Journal of Cancer. 82 (2017) - p. 237-246 , 2017

Link: https://doi.org/10.1016/..

12

Inhibition of EGFR, HER2, and HER3 signaling with AZD8931 i..:

Johnston, Stephen ; Basik, Mark ; Hegg, Roberto...
Breast Cancer Research and Treatment. 160 (2016) 1 - p. 91-99 , 2016

Link: https://doi.org/10.1007/..

13

HannaH phase III randomised study: Association of total pat..:

Jackisch, Christian ; Hegg, Roberto ; Stroyakovskiy, Daniil...
European Journal of Cancer. 62 (2016) - p. 62-75 , 2016

Link: https://doi.org/10.1016/..

14

A phase III, randomized, non-inferiority study comparing th..:

Hegg, Roberto ; Mattar, André ; de Matos Neto, João Nunes...
Clinics. 71 (2016) 10 - p. 586-592 , 2016

Link: https://doi.org/10.6061/..

15

PO56 BOLERO-4: A PHASE 2, OPEN-LABEL, MULTICENTER, SINGLE-A..:

Bachelot, Thomas ; Villanueva, Cristian ; Royce, Melanie...
The Breast. 24 (2015) - p. S41 , 2015

Link: https://doi.org/10.1016/..